Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing

Ceritinib (CER) is a potent drug that has been recently approved by the Food and Drug Administration for the treatment of patients with non-small cell lung cancer harboring the anaplastic lymphoma kinase mutation gene. The existing methods for the quality control of CER are very limited and suffer f...

Full description

Bibliographic Details
Main Authors: Reem M. Abuhejail, Nourah Z. Alzoman, Ibrahim A. Darwish
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/20/7054
_version_ 1827720351138709504
author Reem M. Abuhejail
Nourah Z. Alzoman
Ibrahim A. Darwish
author_facet Reem M. Abuhejail
Nourah Z. Alzoman
Ibrahim A. Darwish
author_sort Reem M. Abuhejail
collection DOAJ
description Ceritinib (CER) is a potent drug that has been recently approved by the Food and Drug Administration for the treatment of patients with non-small cell lung cancer harboring the anaplastic lymphoma kinase mutation gene. The existing methods for the quality control of CER are very limited and suffer from limited analytical throughput and do not meet the requirements of the green analytical principles. This study presented the first-ever development and validation of three innovative green and high-throughput microwell spectrophotometric methods (MW-SPMs) for the quality control of CER in its dosage form (Zykadia<sup>®</sup> capsules). These MW-SPMs were based on the formation of colored <i>N</i>-vinylamino-substituted haloquinone derivatives of CER upon its reactions with each of chloranil, bromanil, and 2,3-dichloro-1,4-naphthoquinone in the presence of acetaldehyde. The optimized procedures of the MW-SPMs were established, and their analytical performances were validated according to the ICH. The linear range of the MW-SPMs was 5–150 µg/mL, with limits of quantitation of 5.3–7.6 µg/mL. The accuracy and precision of the MW-SPMs were proved, as the average recovery values were 99.9–101.0%, and the relative standard deviations did not exceed 1.8%. The three methods were applied to the determination of CER content in Zykadia<sup>®</sup> capsules and drug content uniformity testing. The greenness of the MW-SPMs was proved using three different metric tools. In addition, these methods encompassed the advantage of high-throughput analysis. In conclusion, the three methods are valuable tools for convenient and reliable application in the pharmaceutical quality control units for CER-containing capsules.
first_indexed 2024-03-10T21:01:09Z
format Article
id doaj.art-edd3f067c3f945b79a88f11c2df3ba9d
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T21:01:09Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-edd3f067c3f945b79a88f11c2df3ba9d2023-11-19T17:32:05ZengMDPI AGMolecules1420-30492023-10-012820705410.3390/molecules28207054Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity TestingReem M. Abuhejail0Nourah Z. Alzoman1Ibrahim A. Darwish2Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi ArabiaCeritinib (CER) is a potent drug that has been recently approved by the Food and Drug Administration for the treatment of patients with non-small cell lung cancer harboring the anaplastic lymphoma kinase mutation gene. The existing methods for the quality control of CER are very limited and suffer from limited analytical throughput and do not meet the requirements of the green analytical principles. This study presented the first-ever development and validation of three innovative green and high-throughput microwell spectrophotometric methods (MW-SPMs) for the quality control of CER in its dosage form (Zykadia<sup>®</sup> capsules). These MW-SPMs were based on the formation of colored <i>N</i>-vinylamino-substituted haloquinone derivatives of CER upon its reactions with each of chloranil, bromanil, and 2,3-dichloro-1,4-naphthoquinone in the presence of acetaldehyde. The optimized procedures of the MW-SPMs were established, and their analytical performances were validated according to the ICH. The linear range of the MW-SPMs was 5–150 µg/mL, with limits of quantitation of 5.3–7.6 µg/mL. The accuracy and precision of the MW-SPMs were proved, as the average recovery values were 99.9–101.0%, and the relative standard deviations did not exceed 1.8%. The three methods were applied to the determination of CER content in Zykadia<sup>®</sup> capsules and drug content uniformity testing. The greenness of the MW-SPMs was proved using three different metric tools. In addition, these methods encompassed the advantage of high-throughput analysis. In conclusion, the three methods are valuable tools for convenient and reliable application in the pharmaceutical quality control units for CER-containing capsules.https://www.mdpi.com/1420-3049/28/20/7054ceritinibmicrowell analysisspectrophotometrygreen analytical approachhigh-throughput analysis
spellingShingle Reem M. Abuhejail
Nourah Z. Alzoman
Ibrahim A. Darwish
Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
Molecules
ceritinib
microwell analysis
spectrophotometry
green analytical approach
high-throughput analysis
title Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
title_full Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
title_fullStr Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
title_full_unstemmed Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
title_short Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing
title_sort three innovative green and high throughput microwell spectrophotometric methods for the quantitation of ceritinib a potent drug for the treatment of alk positive non small cell lung cancer an application to the analysis of capsules and drug uniformity testing
topic ceritinib
microwell analysis
spectrophotometry
green analytical approach
high-throughput analysis
url https://www.mdpi.com/1420-3049/28/20/7054
work_keys_str_mv AT reemmabuhejail threeinnovativegreenandhighthroughputmicrowellspectrophotometricmethodsforthequantitationofceritinibapotentdrugforthetreatmentofalkpositivenonsmallcelllungcanceranapplicationtotheanalysisofcapsulesanddruguniformitytesting
AT nourahzalzoman threeinnovativegreenandhighthroughputmicrowellspectrophotometricmethodsforthequantitationofceritinibapotentdrugforthetreatmentofalkpositivenonsmallcelllungcanceranapplicationtotheanalysisofcapsulesanddruguniformitytesting
AT ibrahimadarwish threeinnovativegreenandhighthroughputmicrowellspectrophotometricmethodsforthequantitationofceritinibapotentdrugforthetreatmentofalkpositivenonsmallcelllungcanceranapplicationtotheanalysisofcapsulesanddruguniformitytesting